🧠 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Aldeyra The (ALDX)

NASDAQ
Currency in USD
Disclaimer
6.030
-0.160(-2.58%)
Closed
After Hours
6.170+0.140(+2.322%)
ALDX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
5.8606.360
52 wk Range
1.4206.740
Prev. Close
6.19
Open
6.28
Day's Range
5.86-6.36
52 wk Range
1.42-6.74
Volume
442,545
Average Volume (3m)
502,200
1-Year Change
-13.36%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
ALDX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
10.000
Upside
+65.837%
Members' Sentiments
Bearish
Bullish
ProTips
7 analysts have revised their earnings downwards for the upcoming period
Show more

Aldeyra The Company Profile

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases. The company also develops ADX-629, an orally administered RASP modulator for treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa, as well as rare retinal diseases characterized by inflammation and vision loss. In addition, it develops ADX-246 in systemic immune-mediated disease; and ADX-248 in geographic atrophy. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Compare ALDX to Peers and Sector

Metrics to compare
ALDX
Peers
Sector
Relationship
P/E Ratio
−9.5x−1.6x−0.6x
PEG Ratio
−0.34−0.030.00
Price/Book
3.6x1.4x2.6x
Price / LTM Sales
-9.3x3.1x
Upside (Analyst Target)
65.8%167.0%55.7%
Fair Value Upside
Unlock0.9%6.9%Unlock

FAQ

What Is the Aldeyra The (ALDX) Stock Price Today?

The Aldeyra The stock price today is 6.03

What Stock Exchange Does Aldeyra The Trade On?

Aldeyra The is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Aldeyra The?

The stock symbol for Aldeyra The is "ALDX."

What Is the Aldeyra The Market Cap?

As of today, Aldeyra The market cap is 358.31M.

What is Aldeyra The Earnings Per Share?

The Aldeyra The EPS is -0.639.

What Is the Next Aldeyra The Earnings Date?

Aldeyra The will release its next earnings report on 06 Nov 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.